Brind.

CID, a company listed on Nasdaq, submitted a drug approval application to the Center for Veterinary Medicine.

2 reports, 2 independent Updated Jun 23
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

CID, a company listed on Nasdaq, submitted a drug approval application to the Center for Veterinary Medicine.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped